ArticleThe Biochemical journal2025
JMJD6 and YBX1 physically interact and regulate HOTAIR proximal promoter.
Article in The Biochemical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Insights into the regulation of the HOTAIR proximal promoter.Biochemical Society transactions · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Earlier, we showed that jumonji domain containing protein 6 (JMJD6) interacted with HOTAIR promoter (-123 to -103 bp, termed JMJD6 interaction region [JIR]) and for maximal induction, an additional (-216 to -123 bp) region was required. In silico prediction and ENCODE data from MCF7 cells showed Y-box interacting protein 1 (YBX1) peaks in this region (YIR). Publicly available mass spectrometry data of proteins following JMJD6 immunoprecipitation identified YBX1 as an interacting partner. In this study, we validate JMJD6-YBX1 interaction in breast cancer cell lines using co-immunoprecipitation assays with recombinant, endogenous and in vitro synthesized proteins. Domain mapping using deletion constructs revealed that the A/P domain of YBX1 interacted with the JMJC domain of JMJD6. These proteins also positively regulated each other's expression in breast cancer cell lines. Further, YBX1 augmented luciferase activity of HOTAIR promoter constructs, pHP216 and pHP123, in MCF7, Vec and JMJD6 overexpressing cells. siRNA-mediated depletion, mutation of YIR region or knocking out YBX1 (YKO cells) diminished luciferase activity. ChIP and ChIP-re-ChIP assays verified co-occupancy of both proteins in the HOTAIR promoter region. Electrophoretic mobility shift assays confirmed complex formation with YIR and JIR probes. Mutation of the YIR region and YKO resulted in loss of complex formation with both probes. Taken together, these data imply that YBX1 is crucial for physically recruiting JMJD6 to the HOTAIR promoter. Their interaction and positive feed-forward loop, perpetuated by JMJD6 and YBX1 inter-regulation, culminates in HOTAIR induction, which in turn is known to drive tumour progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.